Very low birth weight (VLBW) preterm infants (<1.5 kg) require up to four times more protein and energy than human milk alone provides. Without adequate fortification, they face poor weight gain and lifelong neurodevelopmental disorders. About 1.5–2% of all newborns fall into this category and need protein-enriched nutrition daily for 2–3 months.
We are developing the BABYLAT Enricher—a novel, automated device that enables hospitals to concentrate the protein and fat fraction from human milk (mother own milk or donor milk) directly on-site. Our proprietary bedside technology allows fast, efficient extraction of human milk protein. No comparable automated solution currently exists on the market. We plan to sell the device and daily filter consumables to large perinatal centers with NICUs.
Babylat secures bi-lateral grant and advances into the clinical stage (startupticker.ch)
Venture Leaders Medtech Roadshow 2025: Swiss Medtech startups shine in Boston (venturelab.swiss)
Babylat: The Venture Leader Medtech improving preterm neonatal care with on-site milk fortifiers (venturelab.swiss)
Venture Leaders Medtech 2025 kick-off their Boston roadshow (venturelab.swiss)
Ten Medtech startups to explore US expansion opportunities (startupticker.ch)
Venture Leaders Medtech 2025: Ten Swiss startups selected for US expansion (venturelab.swiss)
12 MedTech- Startups profitieren vom Booster-Programm (startupticker.ch)
Swiss-Polish grant approved